Search Results 81-90 of 17102 for nivolumab
... nivolumab in each disease cohort, both across and within tumor biomarker subgroups. Participation eligibility. Participant eligibility includes age, gender ...
... nivolumab, may work by stimulating the immune system to attack cancer tumor cells. A Study to Evaluate the Use of Nivolumab and Pomalidomide Combination for ...
The purpose of this study is to determine confirmed objective response with CMP-001 in combination with nivolumab in subjects with refractory unresectable or ...
... Nivolumab in Patients With Advanced Solid Tumors. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info ...
This randomized phase II clinical trial studies how well nivolumab after combined modality therapy works in treating patients with high risk stage II-IIIB anal ...
This phase II trial tests how well nivolumab in combination with chemotherapy drugs along with radiation therapy works in treating patients with nasopharyngeal ...
Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...
... nivolumab in each disease cohort, both across and within tumor biomarker subgroups. ... Giving nivolumab with the usual chemotherapy may work better than ...
Monoclonal antibodies, such as nivolumab, may interfere with the ability of cancer cells to grow and spread. Midostaurin may stop the growth of cancer cells ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!